J. Kalk

发表

Long-term effectiveness of high-dosed ornithine-aspartate on urea synthesis rate and portal hypertension in human liver cirrhosis

D. Müting, J. Kalk, C. Klein, 1992, Amino Acids.

[Causes and diagnostic criteria of hepatic coma--an analysis of 560 cases].

J. Reikowski, D. Müting, J. Kalk, 1983, Leber, Magen, Darm.

Spontaneous regression of oesophageal varices after long-term conservative treatment. Retrospective study in 20 patients with alcoholic liver cirrhosis, posthepatitic cirrhosis and haemochromatosis with cirrhosis.

D. Müting, J. Kalk, R. Fischer, 1990, Journal of hepatology.

Incidence and causes of hyperthyroidism in blacks.

W. Kalk, J. Kalk, Kalk Wj, 1989, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: A prospective study

M. Mercado, D. Müting, J. Kalk, 1991, The British journal of surgery.

Improved results with selective distal splenorenal shunt in a highly selected patient population. A prospective study.

M. A. Mercado, J. Kalk, K. Paquet, 1989, Annals of surgery.

Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 years.

J. Pausch, H. Pointner, R. Klein, 2008, Liver.

Radioactive iodine (131I) therapy for thyrotoxicosis at Groote Schuur Hospital over a 6-year period.

S. Epstein, J. Sagel, W. van Mieghem, 1972, Postgraduate medical journal.

Menstrual Disturbances in Chronic Renal Failure

J. Morley, S. Epstein, J. Sagel, 1979, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Letter: Metabolism of barbiturate after overdosage.

B. Whiting, D. Sumner, J. Kalk, 1975, British medical journal.

Hepatic detoxification and hepatic function in chronic active hepatitis with and without cirrhosis

J. Reikowski, D. Müting, J. Kalk, 2005, Digestive Diseases and Sciences.

Radioactive iodine (1311) therapy forthyrotoxicosis at Groote Schuur Hospital overa6-year period

S. Epstein, J. Sagel, J. Kalk, 1972 .

A comparison of sucralfate with placebo in the treatment of esophageal ulcers following therapeutic endoscopic sclerotherapy of esophageal varices--a prospective controlled randomized trial.

J. Kalk, R. Keinath, K. Paquet, 1991, The American journal of medicine.

Hepatic chemoinfusion of 5-FU in metastasis of gastrointestinal cancer and advanced primary hepatocellular carcinoma.

M. A. Mercado, J. Kalk, K. Paquet, 1992, European Journal of Surgical Oncology.

Long-term endoscopic injection sclerotherapy of bleeding esophageal varices

M. A. Mercado, J. Kalk, K. Paquet, 1989, Surgical Endoscopy.

Immediate endoscopic sclerosis of bleeding esophageal varices

J. Kalk, K. Paquet, P. Koussouris, 1988, Surgical Endoscopy.

Hepatic arterial pulsatility index in cirrhosis: correlation with portal pressure.

J. Kalk, C. Klein, A. Schneider, 1999, Journal of hepatology.

Analysis of a prospective series of 100 mesocaval interposition shunts for bleeding portal hypertension.

M. A. Mercado, D. Müting, J. Kalk, 1990, Hepato-gastroenterology.

Prophylactic Sclerotherapy for Esophageal Varices in High-Risk Cirrhotic Patients Selected by Endoscopic and Hemodynamic Criteria: a Randomized, Single-Center Controlled Trial

J. Kalk, C. Klein, K. Paquet, 1994, Endoscopy.

Mesocaval interposition shunt with small‐diameter polytetrafluoroethylene grafts in sclerotherapy failure

R. Kuhn, J. Kalk, K. Paquet, 1995, The British journal of surgery.

Prospective evaluation and long-term results of mesocaval interposition shunts.

J. Kalk, K. Paquet, P. Koussouris, 1987, Acta chirurgica Scandinavica.